Clinical Trial Update: Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessing the safety and tolerability of JPI-547 in combination with Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel for locally ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• JPI-547

Snippet

Sponsor: Onconic Therapeutics Inc. | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: RECRUITING